RE:Coming faster than expectedEuro007 wrote:
https://www.medtechdive.com/news/grail-files-for-100m-ipo-ahead-of-2021-launch-of-multi-cancer-liquid-biops/584906/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue:%202020-09-09%20MedTech%20Dive%20%5Bissue:29548%5D&utm_term=MedTech%20Dive
The studys 12 cancer typesand the tests sensitivity rates for detecting stage I-III diseaseincluded anorectal (79%), colorectal (74%), esophageal (76%), gastric (78%), head and neck (86%), hormone receptor negative breast (64%), liver (68%), lung (59%), ovarian (67%) and pancreatic (78%) tumors, as well as multiple myeloma (71%) and lymphomas (70%), excluding leukemias. Sensitivity is garbage.....need 90% or better like Aristotle....they have one BIG thing going for them.....MONEY..... They will have to improve the sensitivity to be taken seriously